For prevention and treatment of facial skin damage, medical device, class III. In 5ml vials for injectable use.
A low molecular weight, non-cross-linked HA with amino acids filling and modeling solution for the dermal matrix. It has an immediate (usually after 12 hours) hydrating, stimulating, toning effect.
Procedure
For each session, 5ml of Linerase Hydro is injected to the treated area. The infiltration pattern that is followed is to inject 0.1 ml of this solution intradermal (or directly subdermal) in a grid pattern at approximately 2 cm intervals over the entire treated area.
The injection treatment is carried out using 30/32 gauze needle (length: 4 mm).
Protocol
One session every 7 days for 4 sessions followed by other 2 sessions every 15 days.
Maintenance treatment: One session every month.
The product must be administered by healthcare professionals only.